Skip to main content

Table 1 Basic characteristic of patients, cycle parameters and reproductive outcomes of different COS protocols

From: The effect of letrozole overlapped with gonadotropin on IVF outcomes in women with DOR or aged over 40 years old with repeated cycles

Group

MLP group

GnRH-a long group

GnRH-anta group

Mild stimulation group

P

Basic characteristic of patients

Number

123

123

123

123

 

Cycle

2.02 ± 0.13bc

1.33 ± 0.06ad

1.54 ± 0.07ad

1.89 ± 0.07bc

< 0.01

Age (y)

37.76 ± 0.44

38.74 ± 0.41

38.63 ± 0.34

38.15 ± 0.42

0.298

BMI (kg/m2)

21.69 ± 0.28

22.36 ± 0.34

22.34 ± 0.26

22.26 ± 0.14

0.109

AMH (ng/ml)

1.14 ± 0.09

1.24 ± 0.08

1.18 ± 0.10

1.03 ± 0.09

0.358

AFC

5.02 ± 0.22c

5.63 ± 0.24

6.04 ± 0.30ad

5.02 ± 0.28c

0.012

Infertile duration (y)

5.33 ± 0.42

4.46 ± 0.35

4.99 ± 0.37

4.42 ± 0.38

0.262

Primary infertile (%)

39.02(48/123) b

18.70(23/123) a

28.46(35/123)

26.02(32/123)

0.005

Basic hormone level

PRLB (µg/L)

12.72(9.30–17.20)

11.43(8.42–15.07)

11.13(8.60-14.72)

11.38(8.53–15.35)

0.260

FSHB (IU/L)

8.76(6.75–12.94)

8.65(7.28–11.12)

9.59(6.97–12.86)

9.70(7.27–12.54)

0.406

LHB (IU/L)

3.95(2.84–5.25)

3.63(2.72–4.92)

3.76(2.93–4.98)

4.22(2.91–5.82)

0.155

E2B (ng/L)

44.50(28.00-63.25)

38.00(27.50–58.00)

43.00(26.75–62.25)

44.50(28.00-59.25)

0.650

TB (nmol/L)

1.10(0.63–1.72)

1.00(0.69–1.46)

1.23(0.68–1.55)

1.12(0.70–1.72)

0.410

Cycle parameters

Days of Gn stimulation (d)

8.02 ± 0.23bc

12.57 ± 0.17acd

8.78 ± 0.19abd

7.48 ± 0.26abc

< 0.01

Total Gn dose (IU)

2338.21 ± 71.30bd

3393.21 ± 73.21acd

2243.09 ± 64.71bd

1145.90 ± 48.09abc

< 0.01

Trigger day

FSH (IU/L)

30.85(24.71–37.07)bcd

23.25(19.58–29.01)ad

21.58(18.67–27.42)ad

16.41(13.70-22.39)abc

< 0.01

LH (IU/L)

3.98(2.34–6.45)bd

1.21(0.93–1.65)acd

3.09(2.01–4.87)bd

5.76(3.03–11.32)abc

< 0.01

E2 (ng/L)

538.00(317.00-1039.75)bc

1407.00(861.00-2471.00)ad

1068.00(665.50–1797.00)ad

743.00(429.00-1182.00)bc

< 0.01

P (µg/L)

0.80(0.59–1.22)

0.96(0.66–1.26)d

0.93(0.63–1.28)

0.75(0.52–1.09)b

0.044

T (nmol/L)

2.12(1.36–2.84)c

1.90(1.67–2.92)

1.59(1.15–1.82)a

-

0.018

Number of follicles ≥ 18 mm

1.92 ± 0.11 cd

2.10 ± 0.13d

1.43 ± 0.11ab

1.08 ± 0.11ab

< 0.01

Follicle output rate (%)

37.58(236/628)cd

36.71(254/692)cd

23.42(174/743)ab

20.87(129/618)b

< 0.01

Endometrial thickness (mm)

9.44 ± 0.21bcd

11.39 ± 0.31ad

10.67 ± 0.25ad

8.35 ± 0.28abc

< 0.01

IVF laboratory parameters

Number of oocytes retrieved

4.46 ± 0.26 bd

6.71 ± 0.42acd

4.64 ± 0.31 bd

2. 54 ± 0.21 abc

< 0.01

MII oocytes retrieved

3.66 ± 0.23 bd

5.65 ± 0.35acd

3.96 ± 0.28 bd

2.12 ± 0.17abc

< 0.01

Available embryos

1.97 ± 0.13bd

2.52 ± 0.14acd

2.10 ± 0.13bd

1.34 ± 0.11 abc

< 0.01

Top-quality embryo rate (%)

52.94(126/238) d

58.77(181/308) d

50.00(125/250)

38.61(61/158) ab

< 0.01

Pregnancy outcomes

Embryo implantation rate (%)

23.14(28/121)

16.47(28/170)

17.05(22/129)

13.56(8/59)

0.347

Clinical pregnancy rate (%)

38.46(35/91) d

26.13(29/111)

29.17(30/103)

17.11(13/76) a

0.022

Miscarriage rate (%)

11.54(3/26)

11.54(3/26)

25.00(5/20)

25.00(2/8)

0.528

Cumulative clinical pregnancy rate (%)

33.33(40/120) d

21.68(31/143)

29.03(36/124)

13.04(15/115) a

0.024

  1. Note: MLP: modified letrozole protocol; BMI: body mass index; AMH: anti mullerian hormone; AFC: antral follicle count; PRL: Prolactin; FSH: follicle stimulating hormone; LH: luteinizing hormone; E2: estradiol; T: testosterone; P: Progesterone; Gn: gonadotropin; B in subscript means basic hormone level
  2. aP < 0.05 when compared with modified letrozole group;
  3. bP < 0.05 when compared with GnRH-a long protocol;
  4. cP < 0.05 when compared with GnRH-ant protocol;
  5. dP < 0.05 when compared with mild stimulation protocol